Tumor Treating Fields (TTFields) is a new treatment modality for GBM, developed and pioneered by Novocure, a global oncology company. Treatment with TTFields has been proven to provide significant ...

ROOT, Switzerland, October 01, 2024--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) will report financial results for the third quarter 2024 on Wednesday, October 30, 2024, before the U.S. financial ...

Novocure has launched Optune, its first TTFields delivery system, for the treatment of glioblastoma multiforme and potentially other solid tumor indications. For over 100 years, surgery ...

NovoCure's TTFields showed mixed clinical results in NSCLC, with minor overall survival improvement, questioning its broader adoption beyond glioblastoma. Financially, NovoCure remains strong with ...

Mr. Danziger, who has served as CEO since 2002, will serve as Senior Advisor into early 2026, and will continue to serve on Novocure’s Board of Directors. These changes will become ...

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor ...

NovoCure Limited 2023 Q3 - Results - Earnings Call Presentation NovoCure Limited (NVCR) Q3 2023 Earnings Call Transcript NovoCure GAAP EPS of -$0.46 beats by $0.07, revenue of $127.32M misses by ...

Novocure Ltd. (NASDAQ:NVCR), a medical technology company specializing in oncology treatments, finds itself at a critical juncture as it navigates market challenges and pipeline opportunities. The ...

NovoCure Limited (NVCR) Q2 2024 Earnings Call Transcript NovoCure Limited 2024 Q2 - Results - Earnings Call Presentation NovoCure GAAP EPS of -$0.31 beats by $0.09, revenue of $150.4M beats by $14.57M ...

Novocure (NASDAQ: NVCR) announced today that management will participate in the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024. William Doyle, Novocure’s Executive ...

Novocure (NASDAQ: NVCR) will report financial results for the third quarter 2024 on Wednesday, October 30, 2024, before the U.S. financial markets open. Novocure management will host a conference ...